SANA

insider transactions

Sana Biotechnology, Inc. — buys & sells by directors, officers and 10% owners (SEC Form 4).

30D 90D 1Y

Net shares · 365d

+5.0K

5.0K buy · 0 sell

Net value · 365d

$105.5K

$105.5K in · $0 out

Sentiment · 365d

Net buying

100% buying · 0% selling

Open-market trades · 365d

5.0K buy · 0 sell

Net buy / sell volume

Tap or hover the chart for daily net volume. Green = net buying, red = net selling.

All transactions

Grant·A
Jun 5, 26

Robert Nelsen

Director, 10% Owner

$0

75.0K sh

Own New
Grant·A
Jun 4, 26

Michelle Seitz

Director

$0

90.0K sh

Own New
Grant·A
Jun 4, 26

Patrick Y Yang

Director

$0

90.0K sh

Own New
Grant·A
Jun 4, 26

Robert L. Rosiello

Director

$0

90.0K sh

Own New
Grant·A
Jun 4, 26

Alise Reicin

Director

$0

90.0K sh

Own New
Grant·A
Jun 4, 26

Robert Nelsen

Director, 10% Owner

$0

90.0K sh

Own New
Grant·A
Jun 4, 26

Richard Mulligan

Director

$0

90.0K sh

Own New
Grant·A
Jun 4, 26

Hans Edgar Bishop

Director

$0

90.0K sh

Own New
Grant·A
Jun 4, 26

Joshua H. Bilenker

Director

$0

90.0K sh

Own New
Grant·A
Apr 6, 26

Hans Edgar Bishop

Director

$0

7.8K sh

Own +0%
Other·F
Mar 9, 26

Susan D. Wyrick

SVP, Finance and Accounting a…

$3.2K

1.0K sh · $3.10

Own -1%
Other·F
Mar 9, 26

Susan D. Wyrick

SVP, Finance and Accounting a…

$10.5K

3.3K sh · $3.13

Own -2%
Other·F
Mar 9, 26

Steve Harr KEY

President & CEO

$39.7K

12.8K sh · $3.10

Own -0%
Other·F
Mar 9, 26

Steve Harr KEY

President & CEO

$36.1K

11.5K sh · $3.13

Own -0%
Exercise·M
Mar 7, 26

Susan D. Wyrick

SVP, Finance and Accounting a…

$0

3.2K sh

Own +100%
Exercise·M
Mar 7, 26

Susan D. Wyrick

SVP, Finance and Accounting a…

$0

3.2K sh

Own +2%
Exercise·M
Mar 7, 26

Steve Harr KEY

President & CEO

$0

50.0K sh

Own +100%
Exercise·M
Mar 7, 26

Steve Harr KEY

President & CEO

$0

50.0K sh

Own +1%
Exercise·M
Mar 6, 26

Susan D. Wyrick

SVP, Finance and Accounting a…

$0

10.4K sh

Own +50%
Exercise·M
Mar 6, 26

Susan D. Wyrick

SVP, Finance and Accounting a…

$0

10.4K sh

Own +6%
Exercise·M
Mar 6, 26

Steve Harr KEY

President & CEO

$0

41.7K sh

Own +50%
Exercise·M
Mar 6, 26

Steve Harr KEY

President & CEO

$0

41.7K sh

Own +1%
Grant·A
Mar 5, 26

Susan D. Wyrick

SVP, Finance and Accounting a…

$0

206.2K sh

Own New
Grant·A
Mar 5, 26

Susan D. Wyrick

SVP, Finance and Accounting a…

$0

45.8K sh

Own New
Grant·A
Mar 5, 26

Steve Harr KEY

President & CEO

$0

900.0K sh

Own New
Grant·A
Mar 5, 26

Steve Harr KEY

President & CEO

$0

200.0K sh

Own New
Grant·A
Mar 4, 26

Alise Reicin KEY

Chief Executive Officer

$0

69.2K sh

Own New
Grant·A
Mar 4, 26

Alise Reicin KEY

Chief Executive Officer

$0

76.5K sh

Own +33%
Other·F
Mar 3, 26

Susan D. Wyrick

SVP, Finance and Accounting a…

$1.9K

491 sh · $3.91

Own -0%
Exercise·M
Mar 2, 26

Susan D. Wyrick

SVP, Finance and Accounting a…

$0

1.5K sh

Own New
Exercise·M
Mar 2, 26

Susan D. Wyrick

SVP, Finance and Accounting a…

$0

1.5K sh

Own +1%
Grant·A
Feb 17, 26

Brian Piper KEY

EVP, Chief Financial Officer

$0

900.0K sh

Own New
Grant·A
Feb 17, 26

Brian Piper KEY

EVP, Chief Financial Officer

$0

200.0K sh

Own New
Buy·P
Feb 11, 26

Alise Reicin KEY

Chief Executive Officer

$52.8K

2.5K sh · $21.10

Own +2%
Buy·P
Feb 11, 26

Alise Reicin KEY

Chief Executive Officer

$52.8K

2.5K sh · $21.10

Own +1%
Other·F
Feb 4, 26

Alise Reicin KEY

Chief Executive Officer

$95.3K

4.1K sh · $23.22

Own -2%
Other·F
Jan 5, 26

Susan D. Wyrick KEY

Acting Chief Financial Office…

$10.3K

2.4K sh · $4.27

Own -1%
Grant·A
Jan 5, 26

Hans Edgar Bishop

Director

$0

6.2K sh

Own +0%
Exercise·M
Jan 2, 26

Susan D. Wyrick KEY

Acting Chief Financial Office…

—

7.5K sh

Own New
Exercise·M
Jan 2, 26

Susan D. Wyrick KEY

Acting Chief Financial Office…

$0

7.5K sh

Own +4%
Exercise·M
Dec 31, 25

Alise Reicin KEY

Chief Executive Officer

—

11.0K sh

Own +91%
Exercise·M
Dec 31, 25

Alise Reicin KEY

Chief Executive Officer

$26.1K

11.0K sh · $2.38

Own +5%

Date▾	Insider	Role	Type	Shares	Own Δ	Price	Value
Jun 5, 2026	Robert Nelsen	Director, 10% Owner	Grant A	75.0K	New	—	$0
Jun 4, 2026	Michelle Seitz	Director	Grant A	90.0K	New	—	$0
Jun 4, 2026	Patrick Y Yang	Director	Grant A	90.0K	New	—	$0
Jun 4, 2026	Robert L. Rosiello	Director	Grant A	90.0K	New	—	$0
Jun 4, 2026	Alise Reicin	Director	Grant A	90.0K	New	—	$0
Jun 4, 2026	Robert Nelsen	Director, 10% Owner	Grant A	90.0K	New	—	$0
Jun 4, 2026	Richard Mulligan	Director	Grant A	90.0K	New	—	$0
Jun 4, 2026	Hans Edgar Bishop	Director	Grant A	90.0K	New	—	$0
Jun 4, 2026	Joshua H. Bilenker	Director	Grant A	90.0K	New	—	$0
Apr 6, 2026	Hans Edgar Bishop	Director	Grant A	7.8K	+0%	—	$0
Mar 9, 2026	Susan D. Wyrick	SVP, Finance and Accounting and Principal Accounting Officer	Other F	1.0K	-1%	$3.10	$3.2K
Mar 9, 2026	Susan D. Wyrick	SVP, Finance and Accounting and Principal Accounting Officer	Other F	3.3K	-2%	$3.13	$10.5K
Mar 9, 2026	Steve Harr KEY	President & CEO	Other F	12.8K	-0%	$3.10	$39.7K
Mar 9, 2026	Steve Harr KEY	President & CEO	Other F	11.5K	-0%	$3.13	$36.1K
Mar 7, 2026	Susan D. Wyrick	SVP, Finance and Accounting and Principal Accounting Officer	Exercise M	3.2K	+100%	—	$0
Mar 7, 2026	Susan D. Wyrick	SVP, Finance and Accounting and Principal Accounting Officer	Exercise M	3.2K	+2%	—	$0
Mar 7, 2026	Steve Harr KEY	President & CEO	Exercise M	50.0K	+100%	—	$0
Mar 7, 2026	Steve Harr KEY	President & CEO	Exercise M	50.0K	+1%	—	$0
Mar 6, 2026	Susan D. Wyrick	SVP, Finance and Accounting and Principal Accounting Officer	Exercise M	10.4K	+50%	—	$0
Mar 6, 2026	Susan D. Wyrick	SVP, Finance and Accounting and Principal Accounting Officer	Exercise M	10.4K	+6%	—	$0
Mar 6, 2026	Steve Harr KEY	President & CEO	Exercise M	41.7K	+50%	—	$0
Mar 6, 2026	Steve Harr KEY	President & CEO	Exercise M	41.7K	+1%	—	$0
Mar 5, 2026	Susan D. Wyrick	SVP, Finance and Accounting and Principal Accounting Officer	Grant A	206.2K	New	—	$0
Mar 5, 2026	Susan D. Wyrick	SVP, Finance and Accounting and Principal Accounting Officer	Grant A	45.8K	New	—	$0
Mar 5, 2026	Steve Harr KEY	President & CEO	Grant A	900.0K	New	—	$0
Mar 5, 2026	Steve Harr KEY	President & CEO	Grant A	200.0K	New	—	$0
Mar 4, 2026	Alise Reicin KEY	Chief Executive Officer	Grant A	69.2K	New	—	$0
Mar 4, 2026	Alise Reicin KEY	Chief Executive Officer	Grant A	76.5K	+33%	—	$0
Mar 3, 2026	Susan D. Wyrick	SVP, Finance and Accounting and Principal Accounting Officer	Other F	491	-0%	$3.91	$1.9K
Mar 2, 2026	Susan D. Wyrick	SVP, Finance and Accounting and Principal Accounting Officer	Exercise M	1.5K	New	—	$0
Mar 2, 2026	Susan D. Wyrick	SVP, Finance and Accounting and Principal Accounting Officer	Exercise M	1.5K	+1%	—	$0
Feb 17, 2026	Brian Piper KEY	EVP, Chief Financial Officer	Grant A	900.0K	New	—	$0
Feb 17, 2026	Brian Piper KEY	EVP, Chief Financial Officer	Grant A	200.0K	New	—	$0
Feb 11, 2026	Alise Reicin KEY	Chief Executive Officer	Buy P	2.5K	+2%	$21.10	$52.8K
Feb 11, 2026	Alise Reicin KEY	Chief Executive Officer	Buy P	2.5K	+1%	$21.10	$52.8K
Feb 4, 2026	Alise Reicin KEY	Chief Executive Officer	Other F	4.1K	-2%	$23.22	$95.3K
Jan 5, 2026	Susan D. Wyrick KEY	Acting Chief Financial Officer and Principal Accounting Officer	Other F	2.4K	-1%	$4.27	$10.3K
Jan 5, 2026	Hans Edgar Bishop	Director	Grant A	6.2K	+0%	—	$0
Jan 2, 2026	Susan D. Wyrick KEY	Acting Chief Financial Officer and Principal Accounting Officer	Exercise M	7.5K	New	—	—
Jan 2, 2026	Susan D. Wyrick KEY	Acting Chief Financial Officer and Principal Accounting Officer	Exercise M	7.5K	+4%	—	$0
Dec 31, 2025	Alise Reicin KEY	Chief Executive Officer	Exercise M	11.0K	+91%	—	—
Dec 31, 2025	Alise Reicin KEY	Chief Executive Officer	Exercise M	11.0K	+5%	$2.38	$26.1K

About SANA insider trading

This page tracks insider transactions for Sana Biotechnology, Inc. (SANA) reported to the U.S. Securities and Exchange Commission on Form 4. Corporate insiders — directors, executive officers and beneficial owners of more than 10% of the stock — must disclose their trades within two business days. Open-market purchases (code P) and sales (code S) made at the insider's discretion are the most-watched opportunistic signals, while awards (A), option exercises (M) and tax-withholding (F) reflect compensation rather than conviction. Trades marked 10b5-1 were made under a pre-arranged plan and are considered routine. A cluster buy — several insiders buying within a short window — is historically a stronger bullish indicator than any single trade.